Clinical epidemiology of hospitalized patients with coronavirus disease 2019 (COVID-19) in Japan: report of the COVID-19 registry Japan
N Matsunaga, K Hayakawa, M Terada… - Clinical Infectious …, 2021 - academic.oup.com
Background There is limited understanding of the characteristics of patients with coronavirus
disease 2019 (COVID-19) requiring hospitalization in Japan. Methods This study included …
disease 2019 (COVID-19) requiring hospitalization in Japan. Methods This study included …
[HTML][HTML] First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics
…, N Matsunaga, K Hayakawa, M Terada… - The Journal of …, 2021 - ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, becomes
clinically manifest in a broad range from mild symptoms to life-threatening multi-organ failure (…
clinically manifest in a broad range from mild symptoms to life-threatening multi-organ failure (…
Prolonged and late-onset symptoms of coronavirus disease 2019
…, Y Osanai, K Tanaka, M Terada… - Open forum …, 2020 - academic.oup.com
Some patients who recover from coronavirus disease 2019 (COVID-19) have prolonged
symptoms such as dyspnea, fatigue, cough, and dysosmia for longer than 120 days after …
symptoms such as dyspnea, fatigue, cough, and dysosmia for longer than 120 days after …
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
M Terada, H Ohtsu, S Saito, K Hayakawa, S Tsuzuki… - BMJ open, 2021 - bmjopen.bmj.com
Objectives To investigate the risk factors contributing to severity on admission. Additionally,
risk factors of worst severity and fatality were studied. Moreover, factors were compared …
risk factors of worst severity and fatality were studied. Moreover, factors were compared …
[HTML][HTML] Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide …
…, K Hayakawa, Y Asai, S Tsuzuki, M Terada… - The Lancet Regional …, 2022 - thelancet.com
Background Before widespread coronavirus disease (COVID-19) vaccinations, Japan
experienced three COVID-19 epidemic waves. This study aimed to evaluate the characteristics of …
experienced three COVID-19 epidemic waves. This study aimed to evaluate the characteristics of …
[HTML][HTML] Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
S Tsuzuki, Y Miyazato, M Terada, S Morioka… - Health and Quality of …, 2022 - Springer
Background The empirical basis for a quantitative assessment of the disease burden imposed
by long-COVID is currently scant. We aimed to inform the disease burden caused by long-…
by long-COVID is currently scant. We aimed to inform the disease burden caused by long-…
Comorbidities as risk factors for severe disease in hospitalized elderly COVID-19 patients by different age-groups in Japan
…, K Hayakawa, N Matsunaga, S Tsuzuki, M Terada… - Gerontology, 2022 - karger.com
Introduction: Old age is an independent risk factor (RF) for severe COVID-19; evidence for
clinico-epidemiological characteristics among elderly COVID-19 patients is scarce. We aimed …
clinico-epidemiological characteristics among elderly COVID-19 patients is scarce. We aimed …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 infection among returnees to Japan from Wuhan, China, 2020
…, K Yamamoto, M Ujiie, M Terada… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
In early 2020, Japan repatriated 566 nationals from China. Universal laboratory testing and
14-day monitoring of returnees detected 12 cases of severe acute respiratory syndrome …
14-day monitoring of returnees detected 12 cases of severe acute respiratory syndrome …
SARS-CoV-2-neutralizing humoral IgA response occurs earlier but is modest and diminishes faster than IgG response
…, Y Shimizu, N Kinoshita-Iwamoto, M Terada… - Microbiology …, 2022 - Am Soc Microbiol
Secretory immunoglobulin A (IgA) plays a crucial role in mucosal immunity for preventing the
invasion of exogenous antigens; however, little is understood about the neutralizing activity …
invasion of exogenous antigens; however, little is understood about the neutralizing activity …
[HTML][HTML] Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
…, Y Asai, A Matsunaga, N Kinoshita, M Terada… - Journal of Infection and …, 2021 - Elsevier
Introduction Among patients with coronavirus disease 2019 (COVID-19), the factors that affect
anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody production …
anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody production …